Pharmala Biotech Holdings Inc. (CSE:MDMA)
Canada · Delayed Price · Currency is CAD 0.2300
-0.0100 (-4.17%)
Aug 28, 2026, 3:39 PM EST
Pharmala Biotech Holdings Market Cap
Pharmala Biotech Holdings has a market cap or net worth of CAD 25.12 million as of August 28, 2026. Its market cap has increased by 81.29% in one year.
Market Cap
25.12M
Enterprise Value
24.88M
Revenue
1.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.23
ChartMarket Cap Chart
Since January 11, 2022, Pharmala Biotech Holdings's market cap has increased from 6.64M to 25.12M, an increase of 278.38%. That is a compound annual growth rate of 33.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 25.12M | 109.76% |
| Dec 31, 2025 | 11.98M | -53.64% |
| Dec 31, 2024 | 25.84M | 112.35% |
| Dec 29, 2023 | 12.17M | 486.37% |
| Dec 30, 2022 | 2.07M | -68.75% |
| Jan 11, 2022 | 6.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Telescope Innovations | 39.20M |
| The More Life Company | 36.56M |
| Thiogenesis Therapeutics | 35.69M |
| Quantum BioPharma | 35.34M |
| Onco-Innovations | 34.16M |
| Resverlogix | 32.71M |
| Lobe Sciences | 28.30M |
| Sharp Therapeutics | 27.37M |